Multiple forms of prostate-specific antigen in serum: Differences in immunorecognition by monoclonal and polyclonal assays

Clinical Chemistry

Volumn 39, Issue 12, 1993, Pages 2483-2491

  Zhou, A M ^a   Tewari, P C ^a   Bluestein, B I ^a   Caldwell, G W ^a   Larsen, F L ^a  

^a Ciba Corning Diagnostics Corporation   (United States)

Author keywords

immunoassays compared; prostate cancer; variation, source of; 1 antichymotrypsin

Indexed keywords

CHYMOTRYPSIN A; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; PROSTATE SPECIFIC ANTIGEN; PROTEINASE INHIBITOR; TUMOR MARKER;

AGED; ANALYTIC METHOD; ARTICLE; CANCER DIAGNOSIS; CASE REPORT; CHROMATOGRAPHY; COMPLEX FORMATION; CONTROLLED STUDY; EARLY DIAGNOSIS; HUMAN; IMMUNOASSAY; IMMUNOBLOTTING; INTERMETHOD COMPARISON; MALE; MOLECULAR WEIGHT; PROSTATE CANCER;

EID: 0027717357     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/39.12.2483     Document Type: Article

References (0)